Eric Hampton
Affiliations: | California Institute for Biomedical Research |
Google:
"Eric Hampton"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Travis S. Young | research scientist | 2015- | California Institute for Biomedical Research |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| McGraw JM, Thelen F, Hampton EN, et al. (2021) JAML promotes CD8 and γδ T cell antitumor immunity and is a novel target for cancer immunotherapy. The Journal of Experimental Medicine. 218 |
| Lee SC, Ma JSY, Kim MS, et al. (2021) A PSMA-targeted bispecific antibody for prostate cancer driven by a small-molecule targeting ligand. Science Advances. 7 |
| Garnar-Wortzel L, Bishop TR, Kitamura S, et al. (2021) Chemical Inhibition of ENL/AF9 YEATS Domains in Acute Leukemia. Acs Central Science. 7: 815-830 |
| Chin EN, Yu C, Vartabedian VF, et al. (2020) Antitumor activity of a systemic STING-activating non-nucleotide cGAMP mimetic. Science (New York, N.Y.). 369: 993-999 |
| Asiaban JN, Milosevich N, Chen E, et al. (2020) Cell-based ligand discovery for the ENL YEATS domain. Acs Chemical Biology |
| Viaud S, Ma JSY, Hardy IR, et al. (2018) Switchable control over in vivo CAR T expansion, B cell depletion, and induction of memory. Proceedings of the National Academy of Sciences of the United States of America |
| Raj D, Yang MH, Rodgers D, et al. (2018) Switchable CAR-T cells mediate remission in metastatic pancreatic ductal adenocarcinoma. Gut |
| Laborda E, Mazagova M, Shao S, et al. (2017) Development of A Chimeric Antigen Receptor Targeting C-Type Lectin-Like Molecule-1 for Human Acute Myeloid Leukemia. International Journal of Molecular Sciences. 18 |
| Yu S, Pearson A, Lim R, et al. (2017) P-262 A PDE4 Inhibitor-antibody Conjugate for Treating Ulcerative Colitis Inflammatory Bowel Diseases. 23 |
| Yu S, Pearson AD, Lim RK, et al. (2016) Targeted delivery of an anti-inflammatory PDE4 inhibitor to immune cells via an antibody-drug conjugate. Molecular Therapy : the Journal of the American Society of Gene Therapy |